Interestingly, hub genes exhibited significant enrichment in pathways “Proteoglycans in cancer”, “HIF-1 signaling pathway”, “EGFR tyrosine kinase inhibitor resistance” and “Colorectal cancer”. The gene discussed is EGFR; the disease is colorectal cancer.